3 results
Approved WMORecruiting
Cohorts 1, 2, and 3 only:The purpose of this study is to evaluate the overall complete response (CR) rate in participants treated with TAR-200 in combination with cetrelimab (Cohort 1), or TAR-200 alone (Cohort 2), or cetrelimab alone (Cohort 3)…
Approved WMORecruiting
Compare neurophysiological biomarkers with symptom control and stimulation parameters to improve stimulation settings for individual patients with Parkinson*s disease, tremor syndromes and dystonia.
Approved WMOCompleted
The purposes of this feasibility study are: • to evaluate the correlation between COPD-related dyspnea and the EMG of respiratory muscles when simulating daily activities, to assess the dyspnea symptom in a more objective (measurable) way; • to…